Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2).

about

Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2).

Item

http://www.wikidata.org/entity/Q40447961

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Novel diaryltriazines with a p ...... valuation of WO2016059647(A2).

@en

type

Item

label

Novel diaryltriazines with a p ...... valuation of WO2016059647(A2).

@en

prefLabel

Novel diaryltriazines with a p ...... valuation of WO2016059647(A2).

@en

P1476

Novel diaryltriazines with a p ...... valuation of WO2016059647(A2).

@en

P2093

Dongwei Kang

http://www.w3.org/2001/XMLSchema#string

Peng Zhan

http://www.w3.org/2001/XMLSchema#string

Wanzhuo Li

http://www.w3.org/2001/XMLSchema#string

Zhongxia Zhou

http://www.w3.org/2001/XMLSchema#string

Zihui Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants

High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.

Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors

Approved Antiviral Drugs over the Past 50 Years

Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus

Design strategies of novel NNRTIs to overcome drug resistance.

Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.

HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design.

P304

9-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543776.2017.1262349

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Boshi Huang

Xinyong Liu

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27855563

http://www.w3.org/2001/XMLSchema#string